[Quo vadis diabetes technology?]
Management of patients with diabetes mellitus who require intensive insulin therapy has changed dramatically. From urine and then whole blood glucose monitoring patients can now wear personal continuous glucose monitors; from using multiple insulin injections they can now deliver subcutaneous insulin continuously using ever-more sophisticated insulin pumps. With the current integration of continuous glucose monitoring and insulin pumps a new era is arriving when "smart" insulin pumps can automate insulin delivery to assure more stable glycemic control while minimizing episodes of hypoglycemia. This review briefly summarizes results of key research studies demonstrating feasibility of the technology. It also discusses patient selection and potential challenges faced by attempting to incorporate diabetes technology into daily clinical practice. Finally, an overview of integrated systems in current and planned clinical trials is presented.